Designing a Formulation of the Nootropic Drug Aniracetam Using 2-Hydroxypropyl-Β-Cyclodextrin Suitable for Parenteral Administration
Pharmaceutics - Switzerland
doi 10.3390/pharmaceutics10040240
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 18, 2018
Authors
Publisher
MDPI AG